Circulating Extracellular Vesicles for Early-disease Thernostics (CEVET)

Keyphrases

1. Acute Myocardial Infraction 7%
2. Alzheimer's Disease Brain 36%
3. Alzheimer's Disease Detection 36%
4. Alzheimer's Disease Diagnosis 36%
5. Amyloid Plaques 36%
6. Anti-Alzheimer Drugs 36%
7. Antibody Conjugates 7%
8. APPPS1 36%
9. Aptamer 50%
10. Aptamer Probe 18%
11. Biomarker Quantification 11%
12. Blood-brain Barrier 36%
13. Bodily Fluids 15%
14. Body Fluids 8%
15. Brain Imaging 36%
16. Cancer Cells 39%
17. Cancer Development 9%
18. Cancer Patients 18%
19. Cancer Serum 12%
20. Cancer Treatment 9%
21. Cancer-associated Proteins 7%
22. Capture DNA 14%
23. Capture Method 7%
24. Carcinoembryonic Antigen 36%
25. Cardiac Biomarkers 36%
26. Cardiac Troponin 36%
27. Catalase 18%
28. Cell Samples 12%
29. Cell-cell Communication 10%
30. Circulating Extracellular Vesicles 36%
31. Commercial ELISA Kit 7%
32. Contrast Agent 36%
33. Control Subjects 9%
34. Culture Media 12%
35. Cyanine 36%
36. Cyanine Fluorophores 36%
37. Detection Device 14%
38. Detection Sensitivity 9%
39. Diagnostic Biomarker 9%
40. Diluted Human Serum 12%
41. Direct Quantification 42%
42. Direct Visualization 42%
43. Disease Diagnosis 10%
44. Disease Progression 36%
45. Disease-associated 15%
46. Disintegration 9%
47. DNA Nanodevice 72%
48. DNAzyme 54%
49. Dual Aptamer 36%
50. Dual Therapy 36%
51. Dual-modal 36%
52. Dual-modal Imaging 36%
53. Dual-modal Nanoprobe 36%
54. Early Alzheimer's Disease 36%
55. Early Detection 36%
56. Early Diagnosis 47%
57. Early Disease 36%
58. Early Intervention 7%
59. Early Response 9%
60. Emergent Nature 7%
61. Enhanced Fluorescence 9%
62. Enhanced Photodynamic Therapy 9%
63. Enhanced Raman 12%
64. Enzyme Amplification 12%
65. Enzyme-free 72%
66. Exosomal microRNA 72%
67. Exosome Biomarker 9%
68. Exosome Detection 9%
69. Exosomes 100%
70. Extracellular Deposits 36%
71. Extracellular Vesicles 32%
72. Flow Cell 9%
73. Fluorescence Assay 15%
74. Fluorescence Imaging 54%
75. Fluorescence Measurement 7%
76. Fluorescence Signal Intensity 7%
77. Fluorescent Dye 7%
78. Fluorescent Indicator 13%
79. Fluorometric Assay 36%
80. Folate 9%
81. Functionalized Magnetic Nanoparticles 21%
82. Gene Silencing 36%
83. Gene Silencing Therapy 18%
84. Glutathione 36%
85. Gold Nanoparticles 36%
86. GSH Level 9%
87. High Efficiency 36%
88. High Selectivity 36%
89. High Sensitivity 40%
90. High Spatial Resolution 36%
91. High Specificity 7%
92. High-throughput Detection 36%
93. Highly Selective 36%
94. Honeycomb MnO2 18%
95. Human Serum 19%
96. Hybridization Chain Reaction 55%
97. Hydrogen Peroxide 9%
98. Imaging Assay 18%
99. Imaging Magnetic Resonance 36%
100. Imaging Probe 36%
101. Imaging Tools 36%
102. Immunomagnetic 36%
103. Immunosensor 36%
104. In Cancer 18%
105. In Situ 36%
106. In Situ Assembly 9%
107. Induced Toxicity 36%
108. Inflammation 8%
109. Living Cells 36%
110. Low Abundance 36%
111. Low Limit of Detection 7%
112. Low Spatial Resolution 36%
113. Magnetic Nanoparticles 72%
114. Magnetic Resonance Imaging 36%
115. Magnetic Resonance Imaging Contrast Agents 36%
116. Magnetic Silica 7%
117. Magnetically Controlled 36%
118. Messenger RNA (mRNA) 36%
119. Metastasis 9%
120. MicroRNA 58%
121. MicroRNA Imaging 36%
122. MicroRNA-21 (miR-21) 18%
123. Microsampling 42%
124. Mn2+ 36%
125. Mn2+ Ions 18%
126. Molecular Recognition 36%
127. Multifunctional Hybrids 9%
128. Myocardial Infraction 14%
129. Nanocarriers 9%
130. Nanocomplex 7%
131. Nanomaterials 36%
132. Nanoparticle-free 36%
133. Nanoprobe 36%
134. Nanostructures 36%
135. Near-infrared Imaging 36%
136. Neuropathology 36%
137. Neuroprotective 36%
138. Neuroprotective Effect 36%
139. NIR-II Fluorophores 36%
140. Non-radial 36%
141. Nucleic Acids 8%
142. O2 Supply 9%
143. Photodynamic 36%
144. Photodynamic Therapy 36%
145. Positron Emission Tomography 36%
146. Pre-purification 7%
147. Probe-based 36%
148. Protein Kinase 9%
149. Raman Signal 12%
150. Reaction Products 14%
151. Reactive Oxygen Species 9%
152. Recognition-based 36%
153. Response to Therapy 9%
154. RNA Exosome 42%
155. RNA Imaging 24%
156. Sandwich Structure 36%
157. Scattering Sensor 36%
158. Secondary Antibody 7%
159. Self-assembly 12%
160. Self-generated 9%
161. Self-sufficiency 9%
162. Senile Plaques 36%
163. Sensitive Sensor 12%
164. Serum Samples 19%
165. Signal Probe 12%
166. Silica-coated Magnetic Nanoparticles 7%
167. Simple Sensor 12%
168. Single Vesicle 72%
169. Singlet Oxygen 9%
170. SiO2 Nanoparticles 7%
171. Specific Antibodies 9%
172. Specific Binding 9%
173. Specific Probe 36%
174. Stoichiometric Analysis 36%
175. Stoichiometry 12%
176. Superparamagnetic Iron Oxide Nanoparticles (SPIONs) 36%
177. Surface Proteins 8%
178. Surface-enhanced Raman Scattering 36%
179. Target Capturing 7%
180. Target-triggered 36%
181. Therapeutic Efficacy 9%
182. Therapy Efficacy 9%
183. Thrombin 36%
184. Thrombin Binding Aptamer 7%
185. Thrombin Concentration 7%
186. Total Internal Reflection 36%
187. Total Internal Reflection Fluorescence 39%
188. Transgenic Mouse Model 36%
189. Treatment Efficacy 14%
190. Treatment Monitoring 36%
191. Treatment Survival 7%
192. Tumor 72%
193. Tumor Exosomes 36%
194. Tumor Hypoxia 9%
195. Tumor Progression 15%
196. Tumor-derived Extracellular Vesicles 36%
197. Turn-on Fluorescence 36%
198. Tyrosine Kinase 9%
199. Ultrasensitive Assay 9%
200. YOYO-1 14%